| J9271 | Injection, pembrolizumab, 1 mg | 10,000 | $40 | $430K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 11,160 | $40 | $424.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 800 | $100 | $79.4K |
| J0897 | Injection, denosumab, 1 mg | 2,940 | $20 | $52.9K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 710 | $70 | $47.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 380 | $120 | $43.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 230 | $150 | $32.9K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 210 | $100 | $21.2K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,410 | $10 | $20.5K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 120 | $150 | $18K |